Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. (Q39044195)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Nicola Clarke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Zuocheng Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Dong Fan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Nirmal Parajuli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ratnadeep Basu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Brendan Putko

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Zamaneh Kassiri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Anthony J Turner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Gavin Y Oudit

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

9 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

167-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Translational success stories: angiotensin receptor 1 antagonists in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Angiotensin-converting enzyme 2 is an essential regulator of heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

The ADAMs: signalling scissors in the tumour microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Loss of p47phox subunit enhances susceptibility to biomechanical stress and heart failure because of dysregulation of cortactin and actin filaments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor α-converting enzyme (TACE/ADAM-17) activation in primary human monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

NAD(P)H oxidase: role in cardiovascular biology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Role of ACE2 in diastolic and systolic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

Myocardial proteases and matrix remodeling in inflammatory heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

ADAM-17: the enzyme that does it all.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.11.017

10.1016/J.YJMCC.2013.11.017

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332999%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference